Patents by Inventor Tristan Wasley

Tristan Wasley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and Compositions for Treating Aging-Associated Impairments with TIMP-2 Recombinant Proteins
    Publication number: 20230399380
    Abstract: Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include recombinant protein constructs employing human TIMP-2 protein for use in treating indications related to aging-related cognitive impairment.
    Type: Application
    Filed: May 9, 2023
    Publication date: December 14, 2023
    Inventors: Jody Berry, Elizabeth Booth, Rachel Britton, Meghan Kerrisk Campbell, Eva Czirr, Charles Holz, Tristan Wasley
  • FUSION PROTEINS COMPRISING SARS-COV-2 NUCLEOCAPSID DOMAINS
    Publication number: 20230303629
    Abstract: A fusion protein includes a SARS-CoV-2 nucleocapsid N-terminal domain and/or a SARS-CoV-2 nucleocapsid C-terminal domain, wherein the fusion protein lacks the SARS-CoV-2 nucleocapsid aggregation domain.
    Type: Application
    Filed: August 17, 2021
    Publication date: September 28, 2023
    Inventors: EFRAIN CEH PAVIA, ELISABETE NASCIMENTO, ELIZABETH A. BOOTH, ZEBULON LAPOINT, CHARLES HOLZ, TRISTAN WASLEY, JODY MELTON WITT
  • ANTI D-DIMER RECOMBINANT ANTIBODIES, METHODS AND USES THEREOF
    Publication number: 20230082465
    Abstract: This application relates to anti-D-Dimer recombinant antibodies that specifically bind to fibrin and fibrinogen degradation products (FDP) such as D-Dimer, fragment DD and fragment D with high binding affinity and do not bind to fragment E and fibrinogen. The present invention also refers to methods and assays for detection of D-Dimer and FDP fragments in samples using said recombinant antibodies.
    Type: Application
    Filed: February 19, 2021
    Publication date: March 16, 2023
    Applicant: F. Hoffmann-La Roche AG
    Inventors: Elizabeth A. Booth, Charles Holz, Tristan Wasley, Virginia Montanini, Jody Berry